At Moterum, we believe good healthcare is designed to improve your life, not just your body. We are ready to spark a renaissance in good healthcare, and we want to start with the most challenging, under-served patient communities — because they, to, deserve the best standard of care.
As a stroke patient, your recovery needs are complex and your life and goals are unique. You deserve an integrative approach with a full team dedicated to your continuing care. Moterum’s Medicare and Medicaid-eligible health service is designed to give you a pathway of daily progress that will empower you to reach your own goals for independence. Our movement-based program provides you with human and technological support that’s proven to move patients forward — even if they’ve previously been told it “won’t get much better”. Your dedicated liaison, PT, OT and MD will be just as committed to your progress as you are. It’s how healthcare should be
When you become part of the Moterum community, you’ll get access to truly holistic, committed care.
PT, OT, and MD
Moterum Daily Vistas
In-app care management
In-app visible progress tracking
Welcome to Moterum. Ready to take a step forward with us?
Reach out today.
How We Serve
The Moterum iStride Solution™ , covered by dozens of patent applications and issued patents, changes the gait of its user to re-pattern the user’s brain so they relearn how to walk, while monitoring, assessing, and engaging through a digital therapeutic platform. The device has successfully been used in clinical trials to help people walk faster, reduce fall risk, and improve balance. It is commercially available with a prescription
We design, develop, and test high impact products in the field of mobility and rehabilitation.
Our projects arise from recognizing the unsolved problems of mobility challenged people. We solve these problems with new technology that we develop to help you and your family live full, mobility independent lives. Our company is focused on sourcing, designing, engineering, manufacturing and selling the highest quality products to significantly impact people through addressing the problems of stroke rehabilitation and other chronic neural disorders.
Currently we have developed a next generation Moterum iStride Solution™, which has completed two clinical trials. We are also beginning clinical trials at Roger C. Peace Rehabilitation Hospital and the Greenville Health System in Greenville, SC with our lower limb stretching device for spasticity.
Founder and CEO
Director of Clinical Operations
Clinical Research Manager
Chief Medical Officer
An exceptional and results-driven Clinician Strategist, Healthcare Administration Executive and Board-Certified Physician with extensive experience in all aspects of practice systems, physician services, anesthesiology, critical care medicine, transesophageal echocardiography, quality operations, finance, process improvement, patient safety, clinical research, investigator-led research, and care transformation.
Proven ability to develop and manage integrated clinical programs that ensure sound medical practices, achieve quality outcomes, and reach financial metrics. A visionary and resourceful turnaround specialist, catalyst for change, and a driver of results through the improvement of processes and operations.
• Named one of 50 experts leading field of patient safety in 2018 by Becker’s.• Held national leadership roles in variety of organizations with keen eye to value-based care and operational excellence.• Broad experience working with national organizations as advocate on payment reimbursement reform models.• Invited national speaker at multiple conferences.
BOARD OF DIRECTORS
He served as the President and Chief Executive Officer of Pernix Therapeutics, LLC. From December 2005 to December 2007, he served as Vice President of Business and Product Development at Pernix and from December 2003 to December 2005, he served as Pernix’s Territory Manager. He was responsible for acquiring companies and products, attracting investors and increasing the overall efficiency. He served at the NFL franchise The New Orleans Saints in their media relations department for three years. He has been a Director of Oncternal Therapeutics, Inc. since February 22, 2017.
He has been an Independent Director of TherapeuticsMD, Inc. since February 28, 2012. He serves as a Director of Pernix Sleep, Inc. and Anthem Vault Inc. He served as a Director of Pernix Therapeutics Holdings, Inc. from January 1, 2007 to February 2014. Mr. Collins earned a BA and an MBA from Nicholls State University in Thibodaux, Louisiana.
Her excellence in the digital health world has garnered numerous awards including, Bio-IT World Best Practices, CIO magazine and CIO.COM awards including the CIO 100 award and CIO 100+ Competitive Advantage award. She has special expertise in executing innovation, information and technology solutions, building businesses, implementing operational excellence programs and developing leaders. Karan has been called a visionary and inspirational leader adept at shaping technical and business strategies, creating an energetic climate for growth and excellence, delivering large-scale goals, and motivating others to achieve their highest levels of growth and performance.
She has a reputation for excellence in creating high performance global teams and organizations and for administering multi-million dollar budgets. A technopreneur, Karan serves as a board member and advisor for technology start-ups, colleges, universities and industry standards organizations.
With more than 25 years of growth-oriented executive leadership in the healthcare provider and technology sectors, Mr. Pinter’s hallmark has been developing arena-changing ecosystems within industry segments experiencing structural discontinuities. He has strategically served as a catalyst for change, driven to improve clinical and business outcomes via technology enablement with success transitioning fee-for-service healthcare operations into value-based care. Keith’s proven abilities in market development, strategic development (M&A) and organizational development has enabled stakeholders in organizations ranging from entrepreneurial to Fortune 500 firms to realize substantial value.
Mr. Pinter has a proven record of achievement in leading organizations through rapid acquisitive and organic growth; possessing a unique combination of commercializing novel business models, operationalizing innovative technologies/platforms, rapidly scaling operations, and operating-at-scale. Keith is an exceptional team-builder, motivator and mentor with a history of building and leading high-performing teams towards consistent and crisp execution during turbulent times.
Keith’s focus on creating a new service delivery paradigm for the chronic disease ecosystem (which includes board leadership of Caduceus Medical, Chiron Psychological, Accolite Digital and cliexa) has led to the formation a platform acquisition investment company specializing in transforming the primary care provider segment into a sustainable risk-bearing enterprise.
David Perryman, J.D., is Chief Operating Officer of Drug Innovation Ventures at Emory University (DRIVE) in Atlanta. He was formerly President, CEO and a founder of Zirus. David has played many roles in his 25 years in the biotechnology industry. In addition to Zirus, David has founded two other biotechnology companies: one was acquired and the second became a publicly traded company. David has served on the Board of Directors of these and other biotechnology companies.
Prior to joining Zirus, he was a shareholder and head of the Biotechnology Patent Practice group at Needle & Rosenberg, an IP boutique law firm. He practiced biotechnology patent law for 20 years delivering patent business strategy to biotech companies, venture capital funds, the CDC, NIH, FDA and numerous universities. He also served as a founder and special advisor to Georgia Venture Partners, a state associated biotech venture capital fund.
David served as a panelist at the Institute of Medicine’s Countermesure/Bioterrorism policy meeting (2010) as well as a featured presenter in Developments in Biodefense and Technology Platforms at the 8th Annual BioDefense Summit 2010. He received the 2014 Industry Growth Award from GaBio, considered the top award in Georgia for contribution to the state’s biotechnology industry.
Chief Revenue Officer
Over 20 years of success providing strategic business insights, executing large-scale projects, and driving companies to win in global marketplaces while maintaining corporate values and delivering benefits to key customers.
– Results-driven leader and strategic visionary with a consistent history of leveraging exceptional business acumen and an ability to delivery valuable solutions by merging business and technology perspectives. – Recognized as dedicated executive with track record of exceeding expectations and simultaneously executing on multiple projects and initiatives. – Competitive leader skilled in developing, empowering, and motivating teams to reach goals and peak performance levels.
Specialties: Strategic Analysis * Large-Scale Project Management & Execution * C-level & Industry Presentations * Product Roadmap Development * Global Product Launch * International Go-to-Market Strategies * Product Marketing * Global OEM & Reseller Agreement Negotiations * Team Building & Leadership